{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:04:50Z","timestamp":1789783490139,"version":"4.0.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1753-4887.2007.tb00353.x","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T22:04:59Z","timestamp":1227823499000},"page":"S147-S151","source":"Crossref","is-referenced-by-count":106,"special_numbering":"supplement s3","title":["Osteoporosis and Inflammation"],"prefix":"10.1093","volume":"65","author":[{"given":"Gregory R.","family":"Mundy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB2|cit2","volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","year":"2004"},{"issue":"suppl 1","key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjmed.2005.12.017","article-title":"Preventing osteoporosis-related fractures: an overview","volume":"119","author":"Gass","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1210\/endo-98-4-1065","article-title":"Failure of estrogens and androgens to inhibit bone resorption in tissue culture","volume":"98","author":"Caputo","year":"1976","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02411258","article-title":"Role of osteoblasts in hormonal control of bone resorption - a hypothesis","volume":"34","author":"Rodan","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i1.10","article-title":"Control of osteoclast differentiation","volume":"8","author":"Reddy","year":"1998","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.177.4051.793","article-title":"Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes","volume":"177","author":"Horton","year":"1972","journal-title":"Science"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/endo-125-3-1142","article-title":"Effects of interleukin-1 on bone turnover in normal mice","volume":"125","author":"Boyce","year":"1989","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.4049\/jimmunol.135.4.2562","article-title":"Purification and partial sequence of human osteo-clast-activating factor: identity with interleukin 1 beta","volume":"135","author":"Dewhirst","year":"1985","journal-title":"J Immunol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/306378a0","article-title":"An interleukin 1 like factor stimulates bone resorption in vitro","volume":"306","author":"Gowen","year":"1983","journal-title":"Nature"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1210\/endo.139.6.6128","article-title":"Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy","volume":"139","author":"Lorenzo","year":"1998","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/endo.136.7.7789332","article-title":"Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovari-ectomy period","volume":"136","author":"Kimble","year":"1995","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jbmr.5650030607","article-title":"Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracy-cline excretion from prelabeled mice","volume":"3","author":"Konig","year":"1988","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.138.3.775","article-title":"Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption","volume":"138","author":"Thomson","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1210\/endo-129-3-1596","article-title":"Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix","volume":"129","author":"Pluijm","year":"1991","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion","volume":"13","author":"Poli","year":"1994","journal-title":"Embo J"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1172\/JCI117130","article-title":"Interleukin-11: a new cytokine critical for osteoclast development","volume":"93","author":"Girasole","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1210\/endo.139.4.5946","article-title":"The cellular actions of interleukin-11 on bone resorption in vitro","volume":"139","author":"Hill","year":"1998","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.4049\/jimmunol.162.5.2754","article-title":"A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2","volume":"162","author":"Ogata","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB27|cit27","first-page":"406","article-title":"Pathogenesis of bone erosions in rheumatoid arthritis","volume":"14","author":"Goldring","year":"2002","journal-title":"CurrOpin Rheumatol"},{"issue":"suppl","key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1902\/jop.2005.76.11-S.2066","article-title":"Periodontitis and rheumatoid arthritis: a review","volume":"76","author":"Bartold","year":"2005","journal-title":"J Periodontol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB29|cit29","doi-asserted-by":"crossref","unstructured":"Anderson KC Shaughnessy JD , Jr. Barlogie B Ha-rousseau JL Roodman GD. Multiple myeloma. He-matology Am Soc Hematol Educ Program 2002 214 240","DOI":"10.1182\/asheducation-2002.1.214"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM197411142912001","article-title":"Evidence for the secretion of an osteoclast stimulating factor in myeloma","volume":"291","author":"Mundy","year":"1974","journal-title":"N Engl J Med"},{"issue":"20 Pt 2","key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1158\/1078-0432.CCR-06-0681","article-title":"Treatment for myeloma bone disease","volume":"12","author":"Yeh","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells","volume":"88","author":"Pacifici","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI119333","article-title":"Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency","volume":"99","author":"Ammann","year":"1997","journal-title":"J Clin Invest"},{"issue":"special no. 1","key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1093\/hmg\/ddi116","article-title":"Phenotypic differences in genetically identical organisms: the epigenetic perspective","volume":"14","author":"Wong","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/ osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem Bio-phys Res Commun"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","article-title":"TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts","volume":"188","author":"Fuller","year":"1998","journal-title":"J Exp Med"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/ar127","article-title":"Bone loss. Factors that regulate osteoclast differentiation: an update","volume":"2","author":"Roux","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","article-title":"Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system","volume":"208","author":"Tanaka","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation","volume":"276","author":"Srivastava","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.191.2.303","article-title":"Arterial inflammation in mice lacking the inter-leukin 1 receptor antagonist gene","volume":"191","author":"Nicklin","year":"2000","journal-title":"J Exp Med"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"osteoprote-gerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early post-menopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/hmg\/ddi469","article-title":"Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context","volume":"15","author":"Chen","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10555-006-9021-3","article-title":"The RANK\/RANKL\/OPG triad in cancer-induced bone diseases","volume":"25","author":"Dougall","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1753-4887.2007.tb00353.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Deno-sumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/65\/suppl_3\/S147\/8394460\/nutritionreviews65-s147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T17:07:03Z","timestamp":1684688823000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-lookup\/doi\/10.1111\/j.1753-4887.2007.tb00353.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1111\/j.1753-4887.2007.tb00353.x","relation":{},"ISSN":["0029-6643"],"issn-type":[{"value":"0029-6643","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}